Zoetis, Inc. (ZTS) delivered third-quarter 2024 adjusted earnings (excluding one-time items) of $1.58 per share, which surpassed the Zacks Consensus Estimate of $1.46 per share. In the year-ago quarter, the company delivered adjusted earnings of $1.36 per share. Total revenues grew 11% year over year to $2.39 billion in the reported quarter, which beat the Zacks Consensus Estimate of $2.29 billion. In the year-ago quarter, the company reported total revenues of $2.15 billion. Shares of Zoetis are gaining in ...

Zoetis Inc. (NYSE:ZTS) Q3 2024 Earnings Conference Call November 4, 2024 8:30 AM ET Company Participants Steve Frank - VP of IR Kristin Peck - CEO Wetteny Joseph - CFO Conference Call Participants Erin Wright - Morgan Stanley Michael Ryskin - Bank of America Brandon Vazquez - William Blair Jon Block - Stifel David Westenberg - Piper Sandler Balaji Prasad - Barclays Glen Santangelo - Jefferies Chris Schott - JPMorgan Chris LoBianco - TD Cowen Navann Ty - BNP Paribas Operator Welcome to the Third Quarter 2024 ...

About this content About Angela Harmantas Angela Harmantas is an Editor at Proactive. She has over 15 years of experience covering the equity markets in North America, with a particular focus on junior resource stocks. Angela has reported from numerous countries around the world, including Canada, the US, Australia, Brazil, Ghana, and South Africa for leading trade publications. Previously, she worked in investor relations and led the foreign direct investment program in Canada for the Swedish government. S ...

| --- | --- | --- | --- | --- | --- | --- | --- | |----------|-----------------|-------|-------|-------|-------|-------|-------| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Third | | | | | | | | | | Quarter | | | | | | | | 2024 | Financial | | | | | | | | November | 4, 2024 Results | | | | | | | | | | | | | | | | Forward-Looking Statements This presentation contains forward-looking statements, which reflect the current views of Zoetis with respect to: business plans or prospect ...

Zoetis (ZTS) came out with quarterly earnings of $1.58 per share, beating the Zacks Consensus Estimate of $1.46 per share. This compares to earnings of $1.36 per share a year ago. These figures are adjusted for nonrecurring items. This quarterly report represents an earnings surprise of 8.22%. A quarter ago, it was expected that this animal health company would post earnings of $1.49 per share when it actually produced earnings of $1.56, delivering a surprise of 4.70%. Over the last four quarters, the compa ...

EXHIBIT 99.1 Zoetis Announces Third Quarter 2024 Results • Reports Revenue of $2.4 Billion, Growing 11%, and Net Income of $682 Million, or $1.50 per Diluted Share, Increasing 14% and 16%, Respectively, on a Reported Basis for Third Quarter 2024 • Delivers 14% Operational Growth in Revenue and 15% Operational Growth in Adjusted Net Income for Third Quarter 2024 • Reports Adjusted Net Income of $716 Million, or Adjusted Diluted EPS of $1.58, for Third Quarter 2024 • Raises Full Year 2024 Revenue Guidance to ...

Wall Street analysts forecast that Zoetis (ZTS) will report quarterly earnings of $1.46 per share in its upcoming release, pointing to a year-over-year increase of 7.4%. It is anticipated that revenues will amount to $2.29 billion, exhibiting an increase of 6.3% compared to the year-ago quarter. The consensus EPS estimate for the quarter has been revised 0.1% lower over the last 30 days to the current level. This reflects how the analysts covering the stock have collectively reevaluated their initial estima ...

Zoetis, Inc. (ZTS) is expected to beat estimates when it reports its third-quarter 2024 results on Nov. 4, before the opening bell.The Zacks Consensus Estimate for the to-be-reported quarter’s revenues is pegged at $2.29 billion. The consensus mark for earnings is pinned at $1.46 per share.Let's see how things might have shaped up for Zoetis in the soon-to-be-reported quarter.Stay up-to-date with all quarterly releases: See Zacks Earnings Calendar.Factors to Consider Regarding ZTS’ Q3 EarningsThe veterinary ...

It is always good to have some companies in your portfolio that have an anticyclical nature. Companies that are less sensitive to fluctuations in the economy, allowing the compounding effect to work undisturbed.I am a Dutch manual therapist (MSc) and a passionate retail investor. My investment journey started in 2021 and from that point my love for investing has begun. Nearly from the start i had a strong preference for dividend growth investing.My investment goal is to retire early with the dividend growth ...

Join iREIT on Alpha today to get the most in-depth research that includes REITs, mREITs, Preferreds, BDCs, MLPs, ETFs, and other income alternatives. 438 testimonials and most are 5 stars. Nothing to lose with our FREE 2-week trial . I make many mistakes. However, remaining bullish on Zoetis Inc. (NYSE: ZTS ) in April wasn't one of them. Back then, the veterinarian healthcare stock cratered due to headlines about potential risks associated with one of its blockbuster Analyst's Disclosure: I/we have no stock ...